Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.05 $870 - $1,050
1,000 Added 25.0%
5,000 $4,000
Q1 2024

May 15, 2024

BUY
$0.91 - $1.26 $3,640 - $5,040
4,000 New
4,000 $4.24 Million
Q4 2023

Aug 14, 2024

SELL
$0.9 - $1.06 $2,160 - $2,544
-2,400 Reduced 60.0%
1,600 $1.54 Million
Q3 2023

Aug 14, 2024

SELL
$0.94 - $1.23 $2,820 - $3,690
-3,000 Reduced 42.86%
4,000 $3.84 Million
Q2 2023

Aug 14, 2024

BUY
$1.1 - $1.54 $4,950 - $6,930
4,500 Added 180.0%
7,000 $8.47 Million
Q4 2022

Aug 14, 2024

SELL
$1.67 - $2.35 $4,175 - $5,875
-2,500 Reduced 50.0%
2,500 $4.65 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $78.9M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.